Related Experiment Video
Updated: Jan 21, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Gut Microbiota, Atherosclerosis, and Therapeutic Targets
Vasileios Mantziaris1, George Kolios2
1From the Department of Clinical Pharmacology and Therapeutics, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
The gut microbiome influences atherosclerosis development through metabolites like trimethylamine-N-oxide and inflammation. Understanding these gut microbiota mechanisms could reveal new therapeutic targets for cardiovascular diseases.
Area of Science:
- Microbiology
- Cardiovascular Science
- Metabolic Disease Research
Background:
- Growing evidence links gut microbiota composition and function to atherosclerosis.
- Gut dysbiosis and specific microbial metabolites, such as trimethylamine-N-oxide (TMAO), are implicated in disease development.
- Intestinal inflammation represents a key pathway connecting the gut ecosystem to metabolic and cardiovascular diseases.
Purpose of the Study:
- To review and synthesize the latest scientific findings on the role of gut microbiota in atherogenesis.
- To highlight the importance of understanding the physiological and pathophysiological mechanisms involved.
- To identify potential novel therapeutic targets for atherosclerosis based on gut microbiota research.
Main Methods:
- Literature review of recent studies on gut microbiota and atherosclerosis.
- Analysis of data concerning microbial metabolites and their impact on cardiovascular health.
- Examination of the role of gut-derived inflammation in disease progression.
Main Results:
- Gut microbiota and its metabolites, notably TMAO, are significant contributors to atherosclerosis.
- Gut dysbiosis is a key factor in the development and progression of the disease.
- Intestinal inflammation provides a mechanistic link between gut health and cardiovascular outcomes.
Conclusions:
- Further research into the precise mechanisms of gut microbiota in atherogenesis is crucial.
- Elucidating these pathways will pave the way for innovative therapeutic strategies.
- Targeting the gut microbiome offers promising avenues for managing and treating cardiovascular diseases.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

